Abstract
Multiplex immunofluorescence images of a tumor bed in a responding patient (A low power; B high power) and the tumor of a nonresponding patient (C low power; D high power). Pathologic response is associated with a dense and diverse immune infiltrate, consistent with the activation of antitumor immunity following BOT/BAL.